A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)

Clinical trial NCT05285982 · COMPLETED

Trial details

NCT number: NCT05285982
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Diseases, Interstitial

Start date: 2022-04-06
Primary completion: 2025-08-13
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.